References
- World Health Organization. Global Tuberculosis Report 2015. Available from: http://www.who.int/tb/publications/global_report/gtbr2015_executive_summary.pdf?ua=1
- World Health Organization. Multidrug-Resistant Tuberculosis (MDR TB) 2015 Update. Available from: http://www.who.int/tb/challenges/mdr/mdr_tb_factsheet.pdf.
- World Health Organization. Use of High Burden Country Lists for TB by WHO in the Post-2015 Era. Available from: http://www.who.int/tb/publications/global_report/high_tb_burdencountrylists2016-2020.pdf
- Revised National TB Control Programme. TB INDIA 2011. Revised National TB Control Programme: Annual Status Report. Central TB Division, Directorate General of Health Services. Macro Graphics Pvt Ltd., Delhi. Available from: http://planningcommission.nic.in/reports/genrep/health/RNTCP_2011.pdf
- National Research Council. Facing the Reality of Drug-Resistant Tuberculosis: Challenges and Potential Solutions in India: Summary of a Joint Workshop by the Institute of Medicine, the Indian National Science Academy and the Indian Council of Medical Research. Washington, DC: The National Academies Press, 2012.
- Seddon JA, Hesseling AC, Marais BJ, McIlleron H, Peloquin CA, Donald PR, et al. Paediatric use of second-line anti-tuberculosis agents: a review. Tuberculosis (Edinb). 2012;92:9–17.
- Shah I, Chilkar S. Clinical profile of drug resistant tuberculosis in children. Indian Pediatr. 2012;49:741–4.
- World Health Organization. Definitions and Reporting Framework for Tuberculosis – 2013 revision. Available from: http://apps.who.int/iris/bitstream/10665/79199/1/9789241505345_eng.pdf
- Shah I, Rahangdale A. Partial extensively drug resistance (XDR) tuberculosis in children. Indian Pediatr. 2011;48:977–9.
- Stoffels K, Allix-Béguec C, Groenen G, Wanlin M, Berkvens D, Mathys V, et al. Multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study. PLoS One. 2013;8:e63128.
- Shah I. Multidrug-resistant tuberculosis in children from 2003 to 2005: a brief report. Indian J Med Microbiol. 2012;30:208–11.
- Johnson R, Streicher EM, Louw GE, Warren RM, van Helden PD, Victor TC. Drug resistance in Mycobacterium tuberculosis. Curr Issues Mol Biol. 2006;8:97–111.
- Verma JS, Nair D, Rawat D, Manzoor N. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis. Indian J Med Microbiol. 2011;29:280–2.
- El Sahly HM, Teeter LD, Jost KC Jr, Dunbar D, Lew J, Graviss EA. Incidence of moxifloxacin resistance in clinical Mycobacterium tuberculosis isolates in Houston. Texas. J Clin Microbiol. 2011;49:2942–5.
- Chiang CY, Enarson DA, Yu MC, Bai KJ, Huang RM, Hsu CJ, et al. Outcome of pulmonary multidrug-resistant tuberculosis: a 6-year follow-up study. Eur Respir J. 2006;28:980–5.
- Patel HB, Mody SK, Patel HB, Patel VA, Patel UD. Disposition kinetic of moxifloxacin following intravenous, intramuscular, and subcutaneous administration in goats. ISRN Vet Sci. 2011;29:584342.
- Cheng AC, Turnidge J, Collington P, Looke D, Barton M, Gottlieb T. Control of fluoroquinolone resistance through successful regulation. Australia. Emerg Infect Dis. 2012;18:1453–60.
- Macías Parra M, Kumate Rodríguez J, Arredondo García JL, López-Vidal Y, Castañón-Arreola M, Balandrano S, et al. Mycobacterium tuberculosis complex genotype diversity and drug resistance profiles in a paediatric population in Mexico. Tuberc Res Treat. 2011;2011:239042.